- NSE
- VAISHALI
- ISIN
- INE972X01022
VAISHALI PHARMA
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹7.02
+₹0.26 (+3.85%)
NSE close ·
VAISHALI PHARMA closed at ₹7.02 on 9 Nov 2026, up 3.85% on the day, and is down 27.93% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹4.88 to ₹9.69.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹94.77 Cr
- Industry P/E
- 35.5
Market cap at the 9 Nov 2026 close. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Jun 2026 | ₹23.47 Cr | ₹1.55 Cr | — | ₹0.12 |
Armor risk check
VAISHALI PHARMA moves about 3× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is VAISHALI PHARMA's share price today?
VAISHALI PHARMA (NSE: VAISHALI) closed at ₹7.02 on 9 Nov 2026, up 3.85% from the previous close of ₹6.76. It traded between ₹6.70 and ₹7.10 that day.
What are VAISHALI PHARMA's 52-week high and low?
Over the last 52 weeks VAISHALI PHARMA traded between ₹4.75 and ₹9.90, adjusted for splits and bonuses.
What are VAISHALI PHARMA's NSE symbol, BSE code and ISIN?
VAISHALI PHARMA has NSE symbol VAISHALI, ISIN INE972X01022.
How has VAISHALI PHARMA performed over 1, 3 and 5 years?
VAISHALI PHARMA's share price return: 1Y −27.93%, 3Y −20.23% a year, 5Y +14.51% a year. Dividends are not included.
What is VAISHALI PHARMA's market cap?
VAISHALI PHARMA's market cap is ₹94.77 Cr at the close on 9 Nov 2026.
Which sector is VAISHALI PHARMA in?
VAISHALI PHARMA is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how VAISHALI PHARMA fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app